Research Antibodies Market - Top Companies and Manufacturers

Companies Dominating the Research Antibodies Landscape

The research antibodies market is competitive with the presence of global and regional players and new players venturing in for the market share. The significant growth potential is owed to the rapid advancements in biotechnology globally along with rising demand for precision medicines.

Some of the key players in the market are:

F. Hoffman- La Roche AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Merck & Co., Inc.
Eli Lilly Company
AstraZeneca
Thermo Fisher Scientific, Inc.
Abcam Plc
PerkinElmer
BGI Group
Jackson ImmunoResearch Inc.
Junshi Biosciences

Browse Key Market Insights with Data Illustration:

Research Antibodies Market Size & Share, Growth Trends 2037

In the News

In July 2024, Thermo Fisher Scientific completed the acquisition of Olink which is expected to complement the life sciences offerings of Thermo Fisher Scientific.
In May 2024, AstraZeneca laid the blueprint to build a USD 1.5 billion manufacturing facility for antibody-drug conjugates (ADC) in Singapore.
In November 2021, Abcam and Nautilus Biotechnology, Inc. announced a strategic partnership. In the partnership, Abcam’s recombinant monoclonal antibody development technologies will enhance the research and development of Nautilus’ reagent.

Frequently Asked Questions (FAQ)

In 2024, the industry size of the research antibodies was valued at 4.8 billion and is expected to rise to USD 5 billion by 2025.

The market size of the research antibodies landscape is projected to surpass USD 9.5 billion by the end of 2037 expanding at a CAGR of 5.9% during the forecast period i.e., between 2025-2037.

The major players in the market are F. Hoffman La Roche AG, Merck & Co., Inc., AstraZeneca, Eli Lilly Company, Thermo Fisher Scientific, Abcam Plc, Immuno Biological Laboratories Co., MBL Life Sciences, PerkinElmer and others.

The primary antibodies segment is expected to capture the highest market share of 77.3% by 2037 and will have considerable growth opportunities during the forecast period, 2024-2037 due to the increasing use in research applications.

The market in North America is projected to hold the largest revenue share of 40.7% by the end of 2037 and provide more business opportunities in the future due to robust technological infrastructure, increasing investment in research & development, and strong regulatory frameworks.

Research Antibodies Market - Top Companies and Manufacturers

Companies Dominating the Research Antibodies Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the research antibodies market?

What is the outlook for the research antibodies market??

Who are the major players dominating the research antibodies market?

Which product segment will capture the significant market share for the research antibodies sector by 2037?

Which region will provide more business opportunities for the growth of the research antibodies market in the future?